361 related articles for article (PubMed ID: 26249031)
1. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
8. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
Wang C; Xiang H; Si H; Guo D; Sun M
Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
11. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
14. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C
Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601
[TBL] [Abstract][Full Text] [Related]
15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
16. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
18. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
19. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
Xu K; Gao J; Yang X; Yao Y; Liu Q
Oncol Rep; 2013 Jun; 29(6):2211-8. PubMed ID: 23545718
[TBL] [Abstract][Full Text] [Related]
20. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma.
Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H
Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
